Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial--a prospective multicentre study.

  • Damir Erkapic
  • Johannes Sperzel
  • Sascha Stiller
  • Ulf Meltendorf
  • Johann Mermi
  • Karl Wegscheider
  • Burkhard Hügl
  • INSURE Investigators

Abstract

Prevention of sudden cardiac death by means of the implantable cardioverter/defibrillator (ICD) is considered to be a lifelong therapy. However, it is still unresolved if patients who never experienced an appropriate ICD intervention during generator longevity really need to undergo device replacement.

Bibliografische Daten

OriginalspracheEnglisch
Aufsatznummer2
ISSN0195-668X
StatusVeröffentlicht - 2013
pubmed 22771679